BioMarin Pharmaceutical Inc
BMRN· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2011 | Q2 2010 | Q2 2009 |
|---|---|---|---|
| Revenue | $110.63M | $91.95M | $82.79M |
| Net Income | -$5.08M | -$477.00K | $1.31M |
| EPS Diluted | -$0.05 | -$0.01 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR